Filters
Other countries
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Mitochondrial DNA depletion syndrome panel. 25-gene NGS panel. Genologica Medica Spain | 50 | 25 |
|
Cataract panel. NGS panel of 69 genes. Genologica Medica Spain | 146 | 69 |
|
Autosomal Dominant Hearing Loss. 25-gene NGS panel. Genologica Medica Spain | 48 | 23 |
|
Dyslipidemia and early atherosclerosis panel. 84-gene NGS panel. Genologica Medica Spain | 133 | 84 |
|
Hereditary ataxias. NGS panel of 139 genes. Genologica Medica Spain | 220 | 139 |
|
Ataxia panel. NGS panel of 157 genes. Genologica Medica Spain | 247 | 156 |
|
Optic atrophy. NGS panel of 13 genes. Genologica Medica Spain | 29 | 13 |
|
Non-syndromic hearing loss panel. 95-gene NGS panel. Genologica Medica Spain | 146 | 94 |
|
Optic atrophy panel. NGS panel of 19 genes. Genologica Medica Spain | 38 | 19 |
|
Retinal dystrophy panel. 260 gene NGS panel. Genologica Medica Spain | 420 | 257 |
|
Neuro-ophthalmology panel. NGS panel of 38 genes. Genologica Medica Spain | 75 | 38 |
|
Comprehensive panel of monogenic diabetes. 28-gene NGS panel. Genologica Medica Spain | 60 | 28 |
|
Mitochondrial genome sequencing Molecular Vision Laboratory United States | 526 | 339 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 5 | 1 |
|
Mitochondrial Panel, Nuclear genes CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 145 | 134 |
|
Hearing Loss, Comprehensive Panel CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 142 | 84 |
|
Hearing Loss Advanced Sequencing and CNV Evaluation Athena Diagnostics Inc United States | 249 | 184 |
|
WFS1-Related Disorders: gene sequencing CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 3 | 1 |
|
Wolfram Syndrome , Panel Massive Sequencing (NGS) CISD2, WFS1 Genes Reference Laboratory Genetics Spain | 2 | 2 |
|
Laboratorio de Genetica Clinica SL Spain | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.